Interpace Diagnostics Group, Inc. Transition Agreements
2 Contracts & Agreements
- Transition Services Agreement, dated July 15, 2019, by and between Interpace BioPharma, Inc. and Cancer Genetics, Inc (Filed With SEC on July 19, 2019)
- TRANSITION SERVICES AGREEMENT (Filed With SEC on November 5, 2014)
